Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ChiCTR2600126471) titled 'Study on the Application of Recombinant Human Thyrotropin Assisted Iodine-131 Therapy for Differentiated Thyroid Cancer' on June 9.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University)

Condition: Differentiated Thyroid Cancer

Recruitment Status: Not Recruiting

Phase: 4

Date of First Enrollment: 2026-06-26

Target Sample Size: Observation group:203;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=310608

Published by HT Digital Content Servi...